Cargando…
Pml represses tumour progression through inhibition of mTOR
The promyelocytic leukaemia gene PML is a pleiotropic tumour suppressor. We have recently demonstrated that PML opposes mTOR-HIF1α-VEGF signalling in hypoxia. To determine the relevance of PML-mTOR antagonism in tumourigenesis, we have intercrossed Pml null mice with Tsc2 heterozygous mice, which de...
Autores principales: | Bernardi, Rosa, Papa, Antonella, Egia, Ainara, Coltella, Nadia, Teruya-Feldstein, Julie, Signoretti, Sabina, Pandolfi, Pier Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
WILEY-VCH Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123467/ https://www.ncbi.nlm.nih.gov/pubmed/21387562 http://dx.doi.org/10.1002/emmm.201100130 |
Ejemplares similares
-
The deubiquitinylation and localization of PTEN are regulated by a HAUSP–PML network
por: Song, Min Sup, et al.
Publicado: (2008) -
HIF factors cooperate with PML-RARα to promote acute promyelocytic leukemia progression and relapse
por: Coltella, Nadia, et al.
Publicado: (2014) -
A Dialog on the First 20 Years of PML Research and the Next 20 Ahead
por: Bernardi, Rosa, et al.
Publicado: (2014) -
PML at Mitochondria-Associated Membranes Is Critical for the Repression of Autophagy and Cancer Development
por: Missiroli, Sonia, et al.
Publicado: (2016) -
PML nuclear bodies contribute to the basal expression of the mTOR inhibitor DDIT4
por: Salsman, Jayme, et al.
Publicado: (2017)